Syngen Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019
March 25, 2020 at 04:00 pm EDT
Share
Syngen Biotech Co., Ltd. announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was TWD 1,297.269 million compared to TWD 1,080.453 million a year ago. Operating income was TWD 242.895 million compared to TWD 166.149 million a year ago. Net income was TWD 188.765 million compared to TWD 133.990 million a year ago. Basic earnings per share was TWD 7.86 compared to TWD 5.8 a year ago. Diluted earnings per share was TWD 7.85 compared to TWD 5.79 a year ago.
Syngen Biotech Co Ltd is a Taiwan-based company mainly engaged in the manufacture and distribution of active pharmaceutical ingredients and health food products. The Companyâs products mainly consist of active pharmaceutical ingredients, health food raw materials, medical equipment, such as bone density analyzers, blood glucose analyzers and biochemical analyzers, as well as animal health products and others. The Company distributes its products mainly in Taiwan, Iran, South Korea and Egypt.
SYNGEN BIOTECH CO.,LTD. 
